Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

XOMA Royalty (XOMA) Research & Development (2016 - 2025)

XOMA Royalty (XOMA) has disclosed Research & Development for 10 consecutive years, with $281000.0 as the latest value for Q4 2025.

  • Quarterly Research & Development fell 67.48% to $281000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Dec 2025, down 40.45% year-over-year, with the annual reading at $1.7 million for FY2025, 40.45% down from the prior year.
  • Research & Development hit $281000.0 in Q4 2025 for XOMA Royalty, up from $69000.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $1.3 million in Q1 2025 to a low of $25000.0 in Q3 2023.
  • Historically, Research & Development has averaged $252700.0 across 5 years, with a median of $48000.0 in 2021.
  • Biggest YoY gain for Research & Development was 3818.18% in 2025; the steepest drop was 94.06% in 2025.
  • Year by year, Research & Development stood at $42000.0 in 2021, then crashed by 33.33% to $28000.0 in 2022, then decreased by 10.71% to $25000.0 in 2023, then soared by 3356.0% to $864000.0 in 2024, then plummeted by 67.48% to $281000.0 in 2025.
  • Business Quant data shows Research & Development for XOMA at $281000.0 in Q4 2025, $69000.0 in Q3 2025, and $69000.0 in Q2 2025.